Urology Department, Sheba Medical Center, Tel-Hashomer, Israel.
Neurourology Unit, Rambam Healthcare Campus, Haifa, Israel.
J Urol. 2016 May;195(5):1550-1555. doi: 10.1016/j.juro.2015.12.049. Epub 2015 Dec 13.
PURPOSE: We performed sham controlled evaluation of penile low intensity shock wave treatment effect in patients unable to achieve sexual intercourse using PDE5i (phosphodiesterase type 5 inhibitor). MATERIALS AND METHODS: This prospective, randomized, double-blind, sham controlled study was done in patients with vasculogenic erectile dysfunction who stopped using PDE5i due to no efficacy. All patients had an erection hardness score of 2 or less with PDE5i. A total of 58 patients were randomized, including 37 treated with low intensity shock waves (12 sessions of 1,500 pulses of 0.09 mJ/mm(2) at 120 shock waves per minute) and 18 treated with a sham probe. In the sham group 16 patients underwent low intensity shock wave treatment 1 month after sham treatment. All patients were evaluated at baseline and 1 month after the end of treatment using validated erectile dysfunction questionnaires and the flow mediated dilatation technique for penile endothelial function. Erectile function was evaluated while patients were receiving PDE5i. RESULTS: In the low intensity shock wave treatment group and the sham group 54.1% and 0% of patients, respectively, achieved erection hard enough for vaginal penetration, that is an EHS (Erection Hardness Score) of 3 (p <0.0001). According to changes in the IIEF-EF (International Index of Erectile Function-Erectile Function) score treatment was effective in 40.5% of men who received low intensity shock wave treatment but in none in the sham group (p = 0.001). Of patients treated with shock waves after sham treatment 56.3% achieved erection hard enough for penetration (p <0.005). CONCLUSIONS: Low intensity shock wave treatment is effective even in patients with severe erectile dysfunction who are PDE5i nonresponders. After treatment about half of them were able to achieve erection hard enough for penetration with PDE5i. Longer followup is needed to establish the place of low intensity shock wave treatment in these challenging cases.
目的:我们对因 PDE5i(磷酸二酯酶 5 抑制剂)无效而停止使用 PDE5i 的血管性勃起功能障碍患者进行了阴茎低强度冲击波治疗效果的假对照评估。
材料和方法:这是一项前瞻性、随机、双盲、假对照研究,纳入了因 PDE5i 无效而停止使用 PDE5i 的血管性勃起功能障碍患者。所有患者在使用 PDE5i 时勃起硬度评分为 2 或以下。共有 58 例患者被随机分组,其中 37 例接受低强度冲击波治疗(12 次,每次 1500 个脉冲,强度为 0.09 mJ/mm²,每分钟 120 个冲击波),18 例接受假探头治疗。在假治疗组中,16 例患者在假治疗 1 个月后接受低强度冲击波治疗。所有患者在基线时和治疗结束后 1 个月均使用经过验证的勃起功能障碍问卷和阴茎内皮功能血流介导扩张技术进行评估。在患者接受 PDE5i 时评估勃起功能。
结果:在低强度冲击波治疗组和假治疗组中,分别有 54.1%和 0%的患者实现了足以进行阴道插入的勃起,即勃起硬度评分(EHS)为 3(p<0.0001)。根据 IIEF-EF(国际勃起功能指数-勃起功能)评分的变化,40.5%接受低强度冲击波治疗的男性治疗有效,但假治疗组中没有男性有效(p=0.001)。在接受假治疗后接受冲击波治疗的患者中,有 56.3%的患者实现了足以进行插入的勃起(p<0.005)。
结论:即使是对 PDE5i 无反应的严重勃起功能障碍患者,低强度冲击波治疗也是有效的。治疗后,约有一半的患者能够在使用 PDE5i 时实现足以插入的勃起。需要更长时间的随访来确定低强度冲击波治疗在这些具有挑战性病例中的地位。
Transl Androl Urol. 2025-7-30